chevron_leftBack
As of 20 June 2026, Trinity League India Ltd. has a market cap of $1.06M USD, ranking #48470 globally and #5025 in India.
It ranks #4304 in the Healthcare sector, and #1354 in the Drug Manufacturers - General industry.
Key Stats
Market Cap
$1.06MUSD
99.99M INR
Enterprise Value
$1.06MUSD
99.74M INR
Revenue (TTM)
$45.75KUSD
4.32M INR
EBITDA (TTM)
$3.16KUSD
298.0K INR
Net Income (TTM)
-$2.75KUSD
-260.0K INR
EBITDA Margin
6.9%
Profit Margin
-6%
PS Ratio
23.2
PB Ratio
3.8
Company Profile
Country (HQ)
Sector
Healthcare
Industry
Drug Manufacturers - General
CEO
Devinder Jain
open_in_new
Employees
10
Founded
1988
Website
trinitygroup.ind.in
open_in_new
warningChart data may be delayed
| 1d | 1w | 1m | 3m | 6m | 1y |
|---|---|---|---|---|---|
| -5% | -1.3% | 9.2% | -0.3% | 10% | 11% |
News
Loading...
Markets
| Exchange | Ticker | Price |
|---|---|---|
|
531846
(TRINITYLEA)
Trinity League India Ltd
ISIN: INE884X01011
TV:
TradingView:
SA:
Stock Analysis:
YF:
Yahoo Finance:
GF:
Google Finance:
BA:
Barron's:
MS:
Morningstar:
|
12.63 INR |
1Market cap is calculated using shares outstanding.
2Float shares are publicly tradable shares, excluding insider-held stock.
About Trinity League India Ltd.
Trinity League India Limited operates in the management and financial consultancy business in India. It offers advice, services, and consultancy across various fields. The company also engages in remote sensing, geographic information systems (GIS), agricultural initiatives, and water resource activities. In addition, it explores, manufactures, markets, and distributes Hydrogel, a potassium- and starch-based agricultural product. The company was formerly known as Dr. Wellman’s Homoeopathic Laboratory Ltd. and changed its name to Trinity League India Limited in July 2012. Trinity League India Limited was incorporated in 1988 and is based in Noida, India.
Similar Companies
| Name |
Market Cap (USD)
diff.
|
PE | Country |
|---|---|---|---|
NSE: SUNPHARMA
|
$45.22B
4M%
4.27T INR
|
39.1
|
|
NSE: DIVISLAB
|
$18.38B
2M%
1.73T INR
|
70.0
|
|
NSE: TORNTPHARM
|
$15.17B
1M%
1.43T INR
|
63.0
|
|
NSE: DRREDDY
|
$11.73B
1M%
1.11T INR
|
19.6
|
|
NSE: MANKIND
|
$9.87B
932K%
931.67B INR
|
52.2
|
|
NSE: ZYDUSLIFE
|
$9.71B
917K%
916.53B INR
|
18.6
|
| Name |
Market Cap (USD)
diff.
|
PE | Country |
|---|---|---|---|
NYSE: LLY
|
$761.68B
72M%
|
38.1
|
|
NYSE: JNJ
|
$547.28B
52M%
|
26.4
|
|
NYSE: ABBV
|
$360.63B
34M%
|
97.4
|
|
SIX: RO
|
$318.3B
30M%
256.25B CHF
|
19.9
|
|
LSE: AZN
|
$284.64B
27M%
215.59B GBP
|
27.6
|
|
NYSE: MRK
|
$274.03B
26M%
|
15.1
|
chevron_leftBack